Literature DB >> 11507055

A human prostatic epithelial model of hormonal carcinogenesis.

Y Wang1, D Sudilovsky, B Zhang, P C Haughney, M A Rosen, D S Wu, T J Cunha, R Dahiya, G R Cunha, S W Hayward.   

Abstract

The effects of stromal and hormonal environment on the immortalized but nontumorigenic human prostatic epithelial cell line BPH-1 were investigated in an in vivo model. BPH-1 cells were recombined with rat urogenital sinus mesenchyme (UGM), and the tissue recombinants were grafted to the renal capsule of adult male athymic mouse hosts. BPH-1 + UGM recombinants formed solid branching epithelial cords with a well-defined basement membrane. The cords canalized to form ductal structures. The mesenchymal cells formed thick sheets of well-differentiated smooth muscle surrounding the epithelium, reinforcing the idea that the epithelium dictates the patterning of prostatic stromal cells. When hosts carrying BPH-1 + UGM tissue recombinants were exposed to testosterone propionate and 17-beta-estradiol (T + E2), the tissue recombinants responded by forming invasive carcinomas, demonstrating mixed, predominantly squamous as well as adenocarcinomatous (small acinar and mucinous) differentiation. When either untreated or T + E2-treated hosts were castrated, epithelial apoptosis was observed in the grafts. When tumors were removed and regrafted to fresh hosts they grew rapidly. Tumors were serially regrafted through six generations. Histologically these tumors consisted largely of focally keratinizing squamous cell carcinoma with high-grade malignant cytological features. BPH-1 cells grown in the absence of UGM survived at the graft site but did not form tumors or organized structures. This behavior was not influenced by the presence or absence of T + E2 stimulation. These data show that an immortalized, nontumorigenic human prostatic epithelial cell line can undergo hormonal carcinogenesis in response to T + E2 stimulation. In addition, the data demonstrate that the stromal environment plays an important role in mediating hormonal carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11507055

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  37 in total

1.  Renal capsule xenografting and subcutaneous pellet implantation for the evaluation of prostate carcinogenesis and benign prostatic hyperplasia.

Authors:  Tristan M Nicholson; Kristen S Uchtmann; Conrad D Valdez; Ashleigh B Theberge; Tihomir Miralem; William A Ricke
Journal:  J Vis Exp       Date:  2013-08-28       Impact factor: 1.355

2.  SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression.

Authors:  Zhihu Ding; Chang-Jiun Wu; Gerald C Chu; Yonghong Xiao; Dennis Ho; Jingfang Zhang; Samuel R Perry; Emma S Labrot; Xiaoqiu Wu; Rosina Lis; Yujin Hoshida; David Hiller; Baoli Hu; Shan Jiang; Hongwu Zheng; Alexander H Stegh; Kenneth L Scott; Sabina Signoretti; Nabeel Bardeesy; Y Alan Wang; David E Hill; Todd R Golub; Meir J Stampfer; Wing H Wong; Massimo Loda; Lorelei Mucci; Lynda Chin; Ronald A DePinho
Journal:  Nature       Date:  2011-02-02       Impact factor: 49.962

3.  Androgen hormone action in prostatic carcinogenesis: stromal androgen receptors mediate prostate cancer progression, malignant transformation and metastasis.

Authors:  Emily A Ricke; Karin Williams; Yi-Fen Lee; Suzana Couto; Yuzhuo Wang; Simon W Hayward; Gerald R Cunha; William A Ricke
Journal:  Carcinogenesis       Date:  2012-04-25       Impact factor: 4.944

4.  The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells.

Authors:  Donald J Vander Griend; Wouter L Karthaus; Susan Dalrymple; Alan Meeker; Angelo M DeMarzo; John T Isaacs
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

5.  Dual-label centromere and telomere FISH identifies human, rat, and mouse cell contribution to Multispecies recombinant urogenital sinus xenografts.

Authors:  Donald J Vander Griend; Yuko Konishi; Angelo M De Marzo; John T Isaacs; Alan K Meeker
Journal:  Prostate       Date:  2009-10-01       Impact factor: 4.104

Review 6.  Cytokine and endocrine signaling in prostate cancer.

Authors:  J Puente Vazquez; E Grande Pulido; L M Anton Aparicio
Journal:  Med Oncol       Date:  2011-08-20       Impact factor: 3.064

Review 7.  A historical perspective on the role of stroma in the pathogenesis of benign prostatic hyperplasia.

Authors:  Gerald R Cunha; William A Ricke
Journal:  Differentiation       Date:  2011-06-30       Impact factor: 3.880

8.  Integrin-linked kinase as a target for ERG-mediated invasive properties in prostate cancer models.

Authors:  Daiana D Becker-Santos; Yubin Guo; Mazyar Ghaffari; Elaine D Vickers; Melanie Lehman; Manuel Altamirano-Dimas; Arusha Oloumi; Junya Furukawa; Manju Sharma; Yuzhuo Wang; Shoukat Dedhar; Michael E Cox
Journal:  Carcinogenesis       Date:  2012-10-01       Impact factor: 4.944

9.  STAT3 inhibition in prostate and pancreatic cancer lines by STAT3 binding sequence oligonucleotides: differential activity between 5' and 3' ends.

Authors:  H Dan Lewis; Ashley Winter; Thomas F Murphy; Snehlata Tripathi; Virendra N Pandey; Beverly E Barton
Journal:  Mol Cancer Ther       Date:  2008-06       Impact factor: 6.261

10.  Persistent exposure to Mycoplasma induces malignant transformation of human prostate cells.

Authors:  Kazunori Namiki; Steve Goodison; Stacy Porvasnik; Robert W Allan; Kenneth A Iczkowski; Cydney Urbanek; Leticia Reyes; Noboru Sakamoto; Charles J Rosser
Journal:  PLoS One       Date:  2009-09-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.